Table 3 Comparison of each marker between the benign and early malignant groups.

From: The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer

 

Benign (n = 29)

Malignant Stage I or II (n = 15)

P value

Biliary MIC-1 (pg/ml), median (range)

12 (0–2153) (n = 29)

678 (0–4429) (n = 14)

<0.01

Serum MIC-1 (pg/ml), median (range)

1800 (804–7410) (n = 27)

2926 (427–6952) (n = 14)

0.12

Serum CA19-9 (U/ml), median (range)

13 (2–15682) (n = 24)

45.1 (2–10478) (n = 15)

0.02

Serum CEA (ng/ml), median (range)

1.6 (0.6–5.9) (n = 23)

2.0 (0.4–4.9) (n = 15)

0.52

  1. MIC-1, macrophage inhibitory cytokine-1.
Back to article page